The global eClinical solutions market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 12% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use sectors. These insights are included in the report as a major market contributor.
E-clinical solution refers to a specialized software-based program used for automating and conducting clinical trials and recording data in real-time. The software aids in managing, maintaining, recording and analyzing clinical data. It includes randomization and trial supply management (RTSM), clinical data management system (CDMS) and clinical trial management system (CTMS). eClinical solutions can be operated through web-based applications, installed on-premises or deployed through cloud-based platforms. These solutions standardize and analyze clinical and operational data through integrated and advanced visualization and analytical techniques. As a result, they are widely used across hospitals, clinics, diagnostic centers and other healthcare institutions.
Significant growth in the biopharmaceutical industries is one of the key factors creating a positive outlook for the market. Pharmaceutical organizations use eClinical solutions to seek regulatory approvals for newly developed medicines and drugs. Moreover, the increasing prevalence of chronic medical ailments and the rising geriatric population requiring immediate medical attention, are providing a thrust to the market growth. As the coronavirus disease (COVID-19) continues to spread across the globe, there has been a significant increase in the requirement for eClinical solutions to develop and monitor the administration of vaccines and manage patient data. In line with this, the widespread adoption of smart medical devices by healthcare providers for improved data standardization is also contributing to the market growth. Additionally, various technological advancements and improvements in the cloud-based eClinical solutions, are acting as other growth-inducing factors. In comparison to the traditionally used web-hosted solutions, cloud-based platforms are easy to integrate, deploy and are highly scalable. Other factors, including improvements in the healthcare infrastructure, especially in the developing economies, along with the implementation of favorable government policies promoting public health, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global eClinical solutions market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product, delivery mode, development phase and end use.
Breakup by Product:
Breakup by Delivery Mode:
Breakup by Development Phase:
Breakup by End Use:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Anju Software Inc., Bioclinica (Merged with ERT Clinical), Bio-Optronics Inc. (Advarra Inc.), DATATRAK International Inc., eClinical Solutions LLC, eClinicalWorks, International Business Machines Corporation, Medidata Solutions (Dassault Systèmes), Oracle Corporation, PAREXEL International Corporation and Signant Health.
|Base Year of the Analysis||2020|
|Segment Coverage||Product, Delivery Mode, Development Phase, End Use, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Anju Software Inc., Bioclinica (Merged with ERT Clinical), Bio-Optronics Inc. (Advarra Inc.), DATATRAK International Inc., eClinical Solutions LLC, eClinicalWorks, International Business Machines Corporation, Medidata Solutions (Dassault Systèmes), Oracle Corporation, PAREXEL International Corporation and Signant Health.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at